Scandinavian ChemoTech
Scandinavian ChemoTech: Starting the year on the right foot (Redeye)
2024-05-08 11:02
Redeye provides an update on Scandinavian ChemoTech following the strong Q1 2024 report. Net sales came in 77% above our estimates, at cSEK1.3m, and the cost control from the company was impressive. We increase our sales estimates, lower the cost base slightly, and increase our valuation.
info@redeye.se (Redeye.se)
Redeye AB - Redeye.se